4-Biphenyl-[1,3]dioxol-5-yl-acetic acid, 97.0%, 1g

(3-Chloro-5-formylphenyl)boronic acid, 98%, 5g

tert-Butyl (1S*,4R*)-4-[(S)-tetrahydrofuran-2-carbonylamino]cyclohexylcarbamate, 1g

Br-Mmc (=4-Bromomethyl-7-methoxycoumarin) [for HPLC Labeling]>98.0%(T)1g

1,3,2-DIOXABOROLANE, 2-(3,5-DIMETHOXY-4-METHYLPHENYL)-4,4,5,5-TETRAMETHYL-, 85.0%, 250mg

2-(3-CYANO-4-METHYL-5-PHENYL-5-(TRIFLUOROMETHYL)FURAN-2(5H)-YLIDENE)MALONONITRILE, 95.0%, 5g

4-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate>98.0%(HPLC)(T)5g

2-(3-Bromo-phenoxy)-ethanol, 96.0%, 25g

1-[(Bromoacetyl)oxy]pyrrolidine-2,5-dione, 97.0%, 5g

N-methyl-N-{[1-(2-methylpropyl)-1H-pyrazol-4-yl]methyl}piperidin-4-amine, 95.0%, 500mg

2-BROMO-1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ETHANONE, 95.0%, 250mg

3,4-Dibromo-5-fluoropyridine, 95.0%, 1g

cis-4-Aminocyclohexanecarbonitrile hydrochloride, 97%, 100mg